4.8 Article

P-Rex1 is required for efficient melanoblast migration and melanoma metastasis

Journal

NATURE COMMUNICATIONS
Volume 2, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms1560

Keywords

-

Funding

  1. Association of International Cancer (AICR) [09-0227]
  2. Medical Research Council
  3. National Institute of Health
  4. American Cancer Society
  5. Cancer Research UK.
  6. Marie Curie Industry
  7. Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C231] Funding Source: researchfish
  8. Cancer Research UK [12481] Funding Source: researchfish
  9. Medical Research Council [MC_PC_U127527200, MC_U127527200, G0901991] Funding Source: researchfish
  10. BBSRC [BBS/E/B/0000C231] Funding Source: UKRI
  11. MRC [MC_U127527200, G0901991, MC_PC_U127527200] Funding Source: UKRI

Ask authors/readers for more resources

Metastases are the major cause of death from melanoma, a skin cancer that has the fastest rising incidence of any malignancy in the Western world. Molecular pathways that drive melanoblast migration in development are believed to underpin the movement and ultimately the metastasis of melanoma. Here we show that mice lacking P-Rex1, a Rac-specific Rho GTPase guanine nucleotide exchange factor, have a melanoblast migration defect during development evidenced by a white belly. Moreover, these P-Rex1(-/-) mice are resistant to metastasis when crossed to a murine model of melanoma. Mechanistically, this is associated with P-Rex1 driving invasion in a Rac-dependent manner. P-Rex1 is elevated in the majority of human melanoma cell lines and tumour tissue. We conclude that P-Rex1 has an important role in melanoblast migration and cancer progression to metastasis in mice and humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available